[Abstract]2025 Nov 18:2025.05.09.653092
Chiangjong W, Chutipongtanate S, Hongeng S (2020) Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review)
1 Currently, as per the evidence, an SGLT2 (sodium-glucose cotransporter 2) inhibitor and/or GLP-1(glucagon-like peptide 1) receptor agonist with proven CV (cardiovascular) benefit should be used in people with type 2 diabetes with established ASCVD (atherosclerotic cardiovascular disease) or indicators of high CV risk, established renal disease, or heart failure
This pilot study found that patients carrying the A1+ allele were more likely to respond and achieve higher weight loss (A1+ genotype: 5.9 3.2%
Whether that tradeoff makes sense for you individually is a conversation to have with your assigned licensed clinician - not a conclusion this article can draw on your behalf
NOTE: Although Super GHK products are assigned a 5.2 (on the Relative Strength Scale) because it is 1st generation copper peptides it typically has a very soothing, gentler effect on sensitive skin types
